Tabrecta® (capmatinib)
for Lung Cancer

Tabrecta (capmatinib) is a kinase inhibitor used to treat adults with metastatic non-small cell lung cancer (NSCLC) that cannot be removed by surgery and has an abnormal MET gene. It works by slowing or stopping the growth of cancer cells.

Heart
Other top medicines used to treat Lung Cancer